J S MALPAS
Overview
Explore the profile of J S MALPAS including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
167
Citations
1375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
MALPAS J, Spray G, Witts L
Br Med J
. 2010 Aug;
1(5493):955-7.
PMID: 20790923
No abstract available.
3.
4.
MALPAS J
Hematol Oncol Clin North Am
. 1998 Apr;
12(2):259-68.
PMID: 9561899
Langerhans cell histiocytosis in the adult is rare, but it is important to recognize its occurrence, as it must be differentiated from lymphoma, myeloma, and a variety of skin conditions...
5.
Leonard R, Smith I, Coleman R, MALPAS J, Nicolson M, Cassidy J, et al.
BMJ
. 1997 Nov;
315(7111):811-2.
PMID: 9345181
No abstract available.
6.
Tirovola E, Biassoni L, Britton K, Kaleva N, Kouykin V, MALPAS J
Br J Cancer
. 1996 Dec;
74(11):1815-20.
PMID: 8956799
Tc-99m 2 methoxy-isobutyl-isonitrile (99mTc-MIBI), also called Sestamibi, is a safe and effective scanning agent in solid tumours. Its use in imaging lesions in multiple myeloma has been studied in 21...
7.
MALPAS J, Norton A
Med Pediatr Oncol
. 1996 Dec;
27(6):540-6.
PMID: 8888814
A study of 47 well-documented patients with Langerhans cell histiocytosis (LCH) showed a slight female preponderance, with onset as late as the ninth decade. The skin was the commonest site...
8.
9.
10.
Ganjoo R, Williams A, MALPAS J
Cancer Chemother Pharmacol
. 1995 Jan;
35(4):343-4.
PMID: 7828279
A total of 15 patients with refractory multiple myeloma (MM; 4 primary unresponsive and 11 relapsed and resistant to re-induction/salvage therapy) received i.v. vincristine on day 1 and oral etoposide...